Bayer EBITDA 2010-2024 | BAYRY

Bayer EBITDA for the quarter ending September 30, 2024 was $1.084B, a 25.05% decline year-over-year.

  • Bayer 2023 EBITDA was 11.507B, a 19.19% decline from 2022.
  • Bayer 2022 EBITDA was 14.239B, a 87.79% increase from 2021.
  • Bayer 2021 EBITDA was 7.582B, a 328.11% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Bayer EBITDA 2010-2024 | BAYRY

  • Bayer 2023 EBITDA was 11.507B, a 19.19% decline from 2022.
  • Bayer 2022 EBITDA was 14.239B, a 87.79% increase from 2021.
  • Bayer 2021 EBITDA was 7.582B, a 328.11% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$759.4B
Novo Nordisk (NVO)$387.1B
Johnson & Johnson (JNJ)$342B
AbbVie (ABBV)$309.5B
Merck (MRK)$251.1B
AstraZeneca (AZN)$207.8B
Novartis AG (NVS)$202.5B
Pfizer (PFE)$151.4B
Sanofi (SNY)$123.7B
Innoviva (INVA)$1.1B